Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical complementarities between proton and carbon therapies.

Jean-Jacques Mazeron1, Georges Noel, Loïc Feuvret

  • 1Centre de protonthérapie d'Orsay, BP 65, 91402 Orsay, France.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|June 23, 2005
PubMed
Summary

Protons offer improved dose distribution for cancer treatment, while high-LET neutrons show promise for resistant tumors. Light ions combine benefits, potentially revolutionizing radiation oncology for deep-seated, x-ray resistant cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contribution of fluorodeoxyglucose positron-emission tomography combined with magnetic resonance imaging for differential diagnosis between radionecrosis and recurrence of treated brain metastasis.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same author

Surface-guided analysis of breast shape changes during postoperative radiotherapy by using a functional map framework.

Medical physics·2026
Same author

From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence.

Journal of neuro-oncology·2026
Same author

Defining physician acceptance of radiosensitivity testing for guiding therapeutic interventions in head and neck cancer: A Delphi consensus study.

Clinical and translational radiation oncology·2026
Same author

Performance of a Vendor System for Systematic Offline Adaptive Breast Helical Radiotherapy.

Cancers·2026
Same author

Dose-dependent cerebrovascular impact of pediatric brain radiotherapy revealed by advanced MRI: the AVARTHEC study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Particle Therapy

Background:

  • Protons offer superior depth-dose distribution compared to photons and electrons.
  • Neutrons provide high Linear Energy Transfer (LET) advantage, beneficial for radioresistant or hypoxic tumors.
  • Current research explores various particle types for enhanced cancer treatment efficacy.

Purpose of the Study:

  • To review the current status and potential applications of protons, neutrons, and light ions in radiation oncology.
  • To highlight the physical and biological advantages of different particle therapies.
  • To discuss the future prospects of high-LET particles in treating complex tumors.

Main Methods:

  • Review of existing literature and clinical evidence for proton, neutron, and light ion therapy.

Related Experiment Videos

  • Analysis of physical dose distribution characteristics (e.g., depth-dose profiles).
  • Evaluation of radiobiological advantages, including LET and cell-killing potential.

    • Main Results:

    • Proton therapy is established for specific cancers like ocular melanoma and chordoma.
    • Neutron therapy shows potential for radioresistant tumors, despite suboptimal dose distribution.
    • Light ions offer a combination of high LET and improved physical dose distribution, showing encouraging preliminary results.

    Conclusions:

    • Particle therapy, including protons and high-LET particles like neutrons and light ions, offers distinct advantages over conventional photon and electron therapy.
    • Light ions represent a promising advancement, potentially enabling effective treatment of deep-seated, x-ray resistant tumors.
    • Further clinical evaluation is warranted to fully realize the potential of these advanced radiation modalities.